Ufa

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Gastric and oesophageal cancer1 trial
• Hidradenitis suppurativa1 trial
• Psoriasis1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting4 trials
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals5 trials

Running trials

• Active, not recruiting

  A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation

  NCT06625333· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

  NCT06517732· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

  NCT06142357· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia

  NCT06148506· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

  NCT00680901· Phase 3· Novartis Pharmaceuticals· Source